These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2060767

  • 1. Properties of a protease-sensitive acceptor component in mouse brain synaptosomes for Clostridium botulinum type B neurotoxin.
    Ogasawara J, Kamata Y, Sakaguchi G, Kozaki S.
    FEMS Microbiol Lett; 1991 Apr 15; 63(2-3):351-5. PubMed ID: 2060767
    [Abstract] [Full Text] [Related]

  • 2. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
    Tsukamoto K, Kohda T, Mukamoto M, Takeuchi K, Ihara H, Saito M, Kozaki S.
    J Biol Chem; 2005 Oct 21; 280(42):35164-71. PubMed ID: 16115873
    [Abstract] [Full Text] [Related]

  • 3. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin.
    Kamata Y, Kimura Y, Hiroi T, Sakaguchi G, Kozaki S.
    Biochim Biophys Acta; 1993 Feb 13; 1156(2):213-8. PubMed ID: 8427878
    [Abstract] [Full Text] [Related]

  • 4. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
    Kozaki S, Kamata Y, Watarai S, Nishiki T, Mochida S.
    Microb Pathog; 1998 Aug 13; 25(2):91-9. PubMed ID: 9712688
    [Abstract] [Full Text] [Related]

  • 5. Binding ability of Clostridium botulinum neurotoxin to the synaptosome upon treatment of various kinds of the enzymes.
    Kitamura M, Sone S.
    Biochem Biophys Res Commun; 1987 Mar 30; 143(3):928-33. PubMed ID: 3566763
    [Abstract] [Full Text] [Related]

  • 6. Interaction between Clostridium botulinum neurotoxin and gangliosides.
    Kitamura M, Iwamori M, Nagai Y.
    Biochim Biophys Acta; 1980 Mar 20; 628(3):328-35. PubMed ID: 6768400
    [Abstract] [Full Text] [Related]

  • 7. Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes.
    Agui T, Syuto B, Oguma K, Iida H, Kubo S.
    J Biochem; 1983 Aug 20; 94(2):521-7. PubMed ID: 6630172
    [Abstract] [Full Text] [Related]

  • 8. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.
    Kozaki S, Miki A, Kamata Y, Ogasawara J, Sakaguchi G.
    Infect Immun; 1989 Sep 20; 57(9):2634-9. PubMed ID: 2668181
    [Abstract] [Full Text] [Related]

  • 9. Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes.
    Dolly JO, Williams RS, Black JD, Tse CK, Hambleton P, Melling J.
    Toxicon; 1982 Sep 20; 20(1):141-8. PubMed ID: 7043781
    [Abstract] [Full Text] [Related]

  • 10. Binding of Clostridium botulinum neurotoxin to the presynaptic membrane in the central nervous system.
    Hirokawa N, Kitamura M.
    J Cell Biol; 1979 Apr 20; 81(1):43-9. PubMed ID: 383721
    [Abstract] [Full Text] [Related]

  • 11. Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes.
    Williams RS, Tse CK, Dolly JO, Hambleton P, Melling J.
    Eur J Biochem; 1983 Mar 15; 131(2):437-45. PubMed ID: 6339240
    [No Abstract] [Full Text] [Related]

  • 12. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes.
    Wadsworth JD, Desai M, Tranter HS, King HJ, Hambleton P, Melling J, Dolly JO, Shone CC.
    Biochem J; 1990 May 15; 268(1):123-8. PubMed ID: 2188647
    [Abstract] [Full Text] [Related]

  • 13. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a.
    Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sato K, Sekiguchi M, Takahashi M, Kozaki S.
    FEBS Lett; 1996 Jan 15; 378(3):253-7. PubMed ID: 8557112
    [Abstract] [Full Text] [Related]

  • 14. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
    Rummel A, Mahrhold S, Bigalke H, Binz T.
    Mol Microbiol; 2004 Feb 15; 51(3):631-43. PubMed ID: 14731268
    [Abstract] [Full Text] [Related]

  • 15. Direct evidence for the specific fixation of Cl. botulinum A neurotoxin to brain matter.
    Habermann E, Heller I.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Feb 15; 287(1):97-106. PubMed ID: 1118043
    [Abstract] [Full Text] [Related]

  • 16. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.
    Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M, Kozaki S.
    J Biol Chem; 1994 Apr 08; 269(14):10498-503. PubMed ID: 8144634
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
    Shone CC, Hambleton P, Melling J.
    Eur J Biochem; 1985 Aug 15; 151(1):75-82. PubMed ID: 3896784
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.